The healthcare provider in an outpatient clinic has prescribed omalizumab (Xolair)to a patient.Which primary outcome will the nurse teach the patient to expect?

Question

Quizplus · Accepted Answer

Omalizumab (Xolair) is a monoclonal antibody that binds to immunoglobulin E (IgE) and reduces the circulating IgE levels. As a result, it can decrease the frequency of asthma exacerbations in patients with allergic asthma. It does not affect expectoration of phlegm, moisture of mucous membranes, or liquefaction of thick secretions.

The Healthcare Provider in an Outpatient Clinic Has Prescribed Omalizumab